Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

Asthma epidemiology and risk factors

(2020) Jessica Stern et al.   Seminars in Immunopathology

Clinical relevance of understanding mitogen-activated protein kinases involved in asthma

(2020) Corrado Pelaia et al.   Expert Review of Respiratory Medicine

Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma

(2020) Joanne E. Kavanagh et al.   CHEST

Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype

(2020) Corrado Pelaia et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life

(2020) Bruno Sposato et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Real-life experience with benralizumab during 6 months

(2020) A. Padilla-Galo et al.   BMC Pulmonary Medicine

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma

(2020) Corrado Pelaia et al.   BIOMEDICINE & PHARMACOTHERAPY

Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility

(2019) Marc Humbert et al.   RESPIRATORY MEDICINE

Different endotypes and phenotypes drive the heterogeneity in severe asthma

(2019) P. Jane McDowell et al.   ALLERGY

Asthma from immune pathogenesis to precision medicine

(2019) Kareem Khalaf et al.   SEMINARS IN IMMUNOLOGY

Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma

(2019) Jonathan Corren et al.   Journal of Allergy and Clinical Immunology-In Practice

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

(2019) Brian L. Graham et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Recent Advances in Severe Asthma

(2019) Nathan Schoettler et al.   CHEST

Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose

(2019) Corrado Pelaia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Eosinophilic Asthma

(2019) Ryan K. Nelson et al.   Journal of Allergy and Clinical Immunology-In Practice

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma

(2019) David J. Jackson et al.   ADVANCES IN THERAPY

Systemic and breath biomarkers for asthma

(2019) Ida Mogensen et al.   Current Opinion in Allergy and Clinical Immunology

Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma

(2018) Bradley E. Chipps et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma

(2018) Roma Sehmi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Asthma

(2018) Alberto Papi et al.   LANCET

Benralizumab in the treatment of severe asthma: design, development and potential place in therapy

(2018) Corrado Pelaia et al.   Drug Design Development and Therapy

Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma

(2018) Corrado Pelaia et al.   Biomed Research International

Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease

(2018) Merin E. Kuruvilla et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study

(2018) Corrado Pelaia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

The Severe Asthma Network in Italy: Findings and Perspectives

(2018) Enrico Heffler et al.   Journal of Allergy and Clinical Immunology-In Practice

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study

(2018) Corrado Pelaia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Asthma and corticosteroids: time for a more precise approach to treatment

(2017) Eleanor M. Dunican et al.   EUROPEAN RESPIRATORY JOURNAL

Dupilumab for the treatment of asthma

(2017) Corrado Pelaia et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

(2017) Frank C. Albers et al.   JOURNAL OF ASTHMA

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

(2017) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

(2017) Corrado Pelaia et al.   Drug Design Development and Therapy

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Gary T Ferguson et al.   Lancet Respiratory Medicine

Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma

(2016) Trung N. Tran et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

(2016) Eugene R Bleecker et al.   LANCET

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

(2016) J Mark FitzGerald et al.   LANCET

Role of biologics in severe eosinophilic asthma – focus on reslizumab

(2016) Girolamo Pelaia et al.   Therapeutics and Clinical Risk Management

Asthma phenotypes and IgE responses

(2015) Antoine Froidure et al.   EUROPEAN RESPIRATORY JOURNAL

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

(2015) Girolamo Pelaia et al.   MEDIATORS OF INFLAMMATION

The immunology of asthma

(2015) Bart N Lambrecht et al.   NATURE IMMUNOLOGY

Asthma

(2015) Stephen T. Holgate et al.   Nature Reviews Disease Primers

Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)

(2014) F. Schleich et al.   RESPIRATORY MEDICINE

Immune Responses to Inhalant Mammalian Allergens

(2014) François Hentges et al.   Frontiers in Immunology

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease

(2013) Peter J. Barnes   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis

(2012) Chun E. Jia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Exhaled Nitric Oxide in Pulmonary Diseases

(2010) Peter J. Barnes et al.   CHEST

MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function

(2010) Roland Kolbeck et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Role of interleukins in the regulation of basophil development and secretion

(2009) Peter Valent et al.   CURRENT OPINION IN HEMATOLOGY

Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

(2007) Gerard E. Kaiko et al.   IMMUNOLOGY